0.6126
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace
What analysts say about Century Therapeutics Inc. stockHigh-impact investment strategies - jammulinksnews.com
What drives Century Therapeutics Inc. stock priceExceptional profit velocity - jammulinksnews.com
Century Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - Autocar Professional
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance
Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com
What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser
University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN
Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser
Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser
What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance
Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser
Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com
Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World
CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com
Century Therapeutics to reduce headcount by 51% - MarketScreener
Century Therapeutics Announces Major Workforce Reduction - TipRanks
Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq
Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World
Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa
Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia
Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World
Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Nuveen Asset Management LLC Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - sharewise
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):